The economic burden of rheumatic heart disease in South Korea

Hye Young Seo, Seok-Jun Yoon, Eun Jung Kim, In Hwan Oh, Yo Han Lee, Young Ae Kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Understanding the impact of rheumatic heart disease (RHD) has become increasingly important among aging populations around the world, and Korea is no exception. This study was conducted to estimate total annual patient costs associated with RHD in Korea for 2008 using nationally representative data. The subjects were South Korean citizens with RHD (ICD-10 codes I01-I09). The primary information for this study was obtained from claims data compiled by the National Health Insurance Corporation of Korea. Direct medical care costs were estimated using expenses paid by insurers and patients for non-covered care and pharmaceutical costs. Direct non-medical costs were estimated using data on transportation costs for hospital visits and costs for caregivers. Indirect costs included the costs of productivity loss and premature death in RHD patients. The economic burden of RHD in 2008 was estimated at $67.25 million US dollars. The indirect costs amounted to 39.04 % (US $26.26 million) of the total RHD costs. When stratified by age, the costs incurred by the group of patients older than 60 years were US $31.63 million. The prevalence of the disease in the same age group was 791.07 cases per 100,000 people. This study confirms that the prevalence of RHD was highest in patients older than 60 years in 2008. Furthermore, the patterns of disease in South Korea were similar to patterns observed in other high-income countries. These findings indicate that secondary prevention strategies for the early detection of RHD are needed in South Korea.

Original languageEnglish
Pages (from-to)1505-1510
Number of pages6
JournalRheumatology International
Volume33
Issue number6
DOIs
Publication statusPublished - 2013 Jun 1

Fingerprint

Rheumatic Heart Disease
Republic of Korea
Economics
Costs and Cost Analysis
Korea
International Classification of Diseases
Insurance Carriers
Pharmaceutical Services
Cost of Illness
Premature Mortality
Hospital Costs
National Health Programs
Secondary Prevention
Health Care Costs
Caregivers
Age Groups
Cross-Sectional Studies

Keywords

  • Direct and indirect costs
  • Economic burden of disease
  • RHD costs
  • Rheumatic heart disease

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

The economic burden of rheumatic heart disease in South Korea. / Seo, Hye Young; Yoon, Seok-Jun; Kim, Eun Jung; Oh, In Hwan; Lee, Yo Han; Kim, Young Ae.

In: Rheumatology International, Vol. 33, No. 6, 01.06.2013, p. 1505-1510.

Research output: Contribution to journalArticle

Seo, Hye Young ; Yoon, Seok-Jun ; Kim, Eun Jung ; Oh, In Hwan ; Lee, Yo Han ; Kim, Young Ae. / The economic burden of rheumatic heart disease in South Korea. In: Rheumatology International. 2013 ; Vol. 33, No. 6. pp. 1505-1510.
@article{8997c6071da04f3491c47d100b425a8a,
title = "The economic burden of rheumatic heart disease in South Korea",
abstract = "Understanding the impact of rheumatic heart disease (RHD) has become increasingly important among aging populations around the world, and Korea is no exception. This study was conducted to estimate total annual patient costs associated with RHD in Korea for 2008 using nationally representative data. The subjects were South Korean citizens with RHD (ICD-10 codes I01-I09). The primary information for this study was obtained from claims data compiled by the National Health Insurance Corporation of Korea. Direct medical care costs were estimated using expenses paid by insurers and patients for non-covered care and pharmaceutical costs. Direct non-medical costs were estimated using data on transportation costs for hospital visits and costs for caregivers. Indirect costs included the costs of productivity loss and premature death in RHD patients. The economic burden of RHD in 2008 was estimated at $67.25 million US dollars. The indirect costs amounted to 39.04 {\%} (US $26.26 million) of the total RHD costs. When stratified by age, the costs incurred by the group of patients older than 60 years were US $31.63 million. The prevalence of the disease in the same age group was 791.07 cases per 100,000 people. This study confirms that the prevalence of RHD was highest in patients older than 60 years in 2008. Furthermore, the patterns of disease in South Korea were similar to patterns observed in other high-income countries. These findings indicate that secondary prevention strategies for the early detection of RHD are needed in South Korea.",
keywords = "Direct and indirect costs, Economic burden of disease, RHD costs, Rheumatic heart disease",
author = "Seo, {Hye Young} and Seok-Jun Yoon and Kim, {Eun Jung} and Oh, {In Hwan} and Lee, {Yo Han} and Kim, {Young Ae}",
year = "2013",
month = "6",
day = "1",
doi = "10.1007/s00296-012-2554-6",
language = "English",
volume = "33",
pages = "1505--1510",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - The economic burden of rheumatic heart disease in South Korea

AU - Seo, Hye Young

AU - Yoon, Seok-Jun

AU - Kim, Eun Jung

AU - Oh, In Hwan

AU - Lee, Yo Han

AU - Kim, Young Ae

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Understanding the impact of rheumatic heart disease (RHD) has become increasingly important among aging populations around the world, and Korea is no exception. This study was conducted to estimate total annual patient costs associated with RHD in Korea for 2008 using nationally representative data. The subjects were South Korean citizens with RHD (ICD-10 codes I01-I09). The primary information for this study was obtained from claims data compiled by the National Health Insurance Corporation of Korea. Direct medical care costs were estimated using expenses paid by insurers and patients for non-covered care and pharmaceutical costs. Direct non-medical costs were estimated using data on transportation costs for hospital visits and costs for caregivers. Indirect costs included the costs of productivity loss and premature death in RHD patients. The economic burden of RHD in 2008 was estimated at $67.25 million US dollars. The indirect costs amounted to 39.04 % (US $26.26 million) of the total RHD costs. When stratified by age, the costs incurred by the group of patients older than 60 years were US $31.63 million. The prevalence of the disease in the same age group was 791.07 cases per 100,000 people. This study confirms that the prevalence of RHD was highest in patients older than 60 years in 2008. Furthermore, the patterns of disease in South Korea were similar to patterns observed in other high-income countries. These findings indicate that secondary prevention strategies for the early detection of RHD are needed in South Korea.

AB - Understanding the impact of rheumatic heart disease (RHD) has become increasingly important among aging populations around the world, and Korea is no exception. This study was conducted to estimate total annual patient costs associated with RHD in Korea for 2008 using nationally representative data. The subjects were South Korean citizens with RHD (ICD-10 codes I01-I09). The primary information for this study was obtained from claims data compiled by the National Health Insurance Corporation of Korea. Direct medical care costs were estimated using expenses paid by insurers and patients for non-covered care and pharmaceutical costs. Direct non-medical costs were estimated using data on transportation costs for hospital visits and costs for caregivers. Indirect costs included the costs of productivity loss and premature death in RHD patients. The economic burden of RHD in 2008 was estimated at $67.25 million US dollars. The indirect costs amounted to 39.04 % (US $26.26 million) of the total RHD costs. When stratified by age, the costs incurred by the group of patients older than 60 years were US $31.63 million. The prevalence of the disease in the same age group was 791.07 cases per 100,000 people. This study confirms that the prevalence of RHD was highest in patients older than 60 years in 2008. Furthermore, the patterns of disease in South Korea were similar to patterns observed in other high-income countries. These findings indicate that secondary prevention strategies for the early detection of RHD are needed in South Korea.

KW - Direct and indirect costs

KW - Economic burden of disease

KW - RHD costs

KW - Rheumatic heart disease

UR - http://www.scopus.com/inward/record.url?scp=84878725522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878725522&partnerID=8YFLogxK

U2 - 10.1007/s00296-012-2554-6

DO - 10.1007/s00296-012-2554-6

M3 - Article

C2 - 23239034

AN - SCOPUS:84878725522

VL - 33

SP - 1505

EP - 1510

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

IS - 6

ER -